PFM Health Sciences’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-742,138
Closed -$14.2M 93
2022
Q3
$14.2M Sell
742,138
-435,112
-37% -$9.98M 0.54% 58
2022
Q2
$21.4M Sell
1,177,250
-705,107
-37% -$14.6M 0.84% 46
2022
Q1
$47.4M Sell
1,882,357
-143,324
-7% -$3.67M 1.83% 21
2021
Q4
$55.9M Sell
2,025,681
-847,237
-29% -$24.5M 1.95% 18
2021
Q3
$92.8M Sell
2,872,918
-216,234
-7% -$7.18M 3.01% 9
2021
Q2
$94.5M Buy
3,089,152
+370,529
+14% +$10.7M 3.04% 8
2021
Q1
$82.8M Buy
+2,718,623
New +$77.2M 2.88% 9
2014
Q2
Sell
-40,491
Closed -$1.38M 73
2014
Q1
$1.38M Sell
40,491
-365,612
-90% -$11.3M 0.03% 70
2013
Q4
$8.52M Buy
406,103
+258,727
+176% +$6.54M 0.17% 53
2013
Q3
$3.46M Buy
+147,376
New +$4.19M 0.08% 68

Other funds holding MYGN